Pactster, a company providing community-based online workouts for people with specific health conditions, is excited to announce a new partnership with the Cystic Fibrosis Trust in the UK. The ...
A 24-week phase 3 trial has found that once-daily vanzacaftor-tezacaftor-deutivacaftor is generally safe and well tolerated in children with cystic fibrosis aged 6-11 years. The treatment maintains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results